DermaProtect is an AI-powered web application designed to help individuals manage dermatillomania (compulsive skin picking). Using your device's webcam, it employs computer vision to detect face-touching behaviors in real-time and provides customizable alerts to help you break the habit. The tool is informed by dermatological research, including studies backed by CSIRO, offering a scientifically-validated approach to support your skin journey.
OpenSynaps is an AI-powered digital wellness platform offering personalized programs to combat stress, anxiety, phobias, and addictions. It combines hypnosis, sophrology, meditation, and a supportive community to help users achieve serenity and balance. The AI adapts programs to individual needs for a truly personal therapeutic experience.
DermaProtect is an AI-powered web application designed to help individuals manage dermatillomania (compulsive skin picking). Using your device's webcam, it employs computer vision to detect face-touching behaviors in real-time and provides customizable alerts to help you break the habit. The tool is informed by dermatological research, including studies backed by CSIRO, offering a scientifically-validated approach to support your skin journey.
OpenSynaps is an AI-powered digital wellness platform offering personalized programs to combat stress, anxiety, phobias, and addictions. It combines hypnosis, sophrology, meditation, and a supportive community to help users achieve serenity and balance. The AI adapts programs to individual needs for a truly personal therapeutic experience.
| Feature | DermaProtect | OpenSynaps |
|---|---|---|
| Primary category | Computer Vision | Mental Health |
| Added | 2025-08-02 | 2025-08-11 |
| Pricing | Paid | Freemium |
| Official website | www.dermaprotect.app | opensynaps.com |
| Product type | Website | Website |
| Performance data | ||
| User rating | Not verified | Not verified |
| Comments | 0 | 0 |
| Monthly visits | 3.4K | 9.5K |
| Monthly growth | Not verified | 20% |
| Favorites | 112 | 129 |
| Details | View details | View details |
Compare DermaProtect and OpenSynaps by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the DermaProtect vs OpenSynaps monthly traffic comparison, DermaProtect currently shows 3.4K visits and OpenSynaps shows 9.5K; OpenSynaps has about 2.8 times the visible traffic of DermaProtect, an absolute difference of about 6.1K visits. This reflects visible reach, not feature quality or paid users.
Only OpenSynaps has complete third-party traffic details; DermaProtect uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇫🇷France | 53.76% | 5.1K |
| 🇪🇸Spain | 27.12% | 2.6K |
| 🇺🇸United States | 19.12% | 1.8K |
This in-depth DermaProtect vs OpenSynaps comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. DermaProtect is primarily listed under “Computer Vision”, while OpenSynaps is primarily listed under “Mental Health”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (DermaProtect: Computer Vision; OpenSynaps: Mental Health); Pricing (DermaProtect: Paid; OpenSynaps: Freemium); Monthly visits (DermaProtect: 3.4K; OpenSynaps: 9.5K); Favorites (DermaProtect: 112; OpenSynaps: 129); Website (DermaProtect: www.dermaprotect.app; OpenSynaps: opensynaps.com). These facts are more useful for selection than brand visibility alone.
In the DermaProtect vs OpenSynaps monthly traffic comparison, DermaProtect currently shows 3.4K visits and OpenSynaps shows 9.5K; OpenSynaps has about 2.8 times the visible traffic of DermaProtect, an absolute difference of about 6.1K visits. This reflects visible reach, not feature quality or paid users.
Only OpenSynaps has complete third-party traffic details; DermaProtect uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
DermaProtect and OpenSynaps currently overlap in shared categories: Habit Formation; shared tags: AI coach, mental health, and wellness. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
DermaProtect's unique categories/tags are Computer Vision, Mental Health, behavior modification, BFRB, computer vision, dermatillomania, face tracking, and habit tracker; OpenSynaps's are Mental Health, Wellness, anxiety, hypnosis, meditation, quit smoking, self-help, and sophrology. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
DermaProtect has no verified rating, 0 comments, 112 favorites, and 124 likes；OpenSynaps has no verified rating, 0 comments, 129 favorites, and 127 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put DermaProtect on the priority trial list when the task aligns with “Computer Vision” and especially Computer Vision, Mental Health, behavior modification, BFRB, computer vision, and dermatillomania. This follows recorded positioning and does not imply unlisted capabilities are absent.
DermaProtect also currently records: pricing is paid, product type is website, 3.4K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put OpenSynaps on the priority trial list when the task aligns with “Mental Health” and especially Mental Health, Wellness, anxiety, hypnosis, meditation, and quit smoking. This follows recorded positioning and does not imply unlisted capabilities are absent.
OpenSynaps also currently records: pricing is freemium, product type is website, 9.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in DermaProtect and OpenSynaps, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
